Cargando…
Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy
Autores principales: | Burke, G. A. Amos, Beishuizen, Auke, Bhojwani, Deepa, Burkhardt, Birgit, Minard-Colin, Véronique, Norris, Robin E., Kabickova, Edita, Pinarli, F. Guclu, Tacyildiz, Nurdan, Howes, Angela, Jong, Jan de, Liu, Grace, Nottage, Kerri, Salman, Mariya, Trixhe, Xavier Woot de, Cairo, Mitchell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387295/ https://www.ncbi.nlm.nih.gov/pubmed/32071430 http://dx.doi.org/10.1038/s41375-020-0749-5 |
Ejemplares similares
-
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial
por: Burke, G. A. Amos, et al.
Publicado: (2022) -
Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
por: Knörr, Fabian, et al.
Publicado: (2021) -
Sparkling cyanide
por: Christie, Agatha, 1890-1976
Publicado: (1981) -
Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy
por: Woot de Trixhe, Xavier, et al.
Publicado: (2021) -
Igniting the sparkle : an indigenous science education model /
por: Cajete, Gregory, 1952-
Publicado: (1999)